POLETTI, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 280
NA - Nord America 179
AS - Asia 15
AF - Africa 11
Totale 485
Nazione #
IT - Italia 183
US - Stati Uniti d'America 177
SE - Svezia 26
DE - Germania 19
IE - Irlanda 13
BG - Bulgaria 8
GB - Regno Unito 8
CN - Cina 7
CI - Costa d'Avorio 6
CH - Svizzera 5
FI - Finlandia 5
IN - India 5
NL - Olanda 5
AT - Austria 3
TG - Togo 3
CA - Canada 2
NG - Nigeria 2
PH - Filippine 2
RS - Serbia 2
ES - Italia 1
FR - Francia 1
JO - Giordania 1
LU - Lussemburgo 1
Totale 485
Città #
Bologna 52
Chandler 29
Fabriano 27
Salsomaggiore Terme 20
Milan 19
Dublin 13
Redmond 12
Ashburn 11
Mondolfo 9
New York 8
Sofia 8
Abidjan 6
Princeton 6
Southend 6
Amsterdam 5
Bern 5
Fairfield 5
Helsinki 5
Reggio Emilia 5
Riola 5
Turin 5
Beijing 4
Florence 4
San Lazzaro Di Savena 4
Berlin 3
Boydton 3
Bremen 3
Lomé 3
Medford 3
Stilo 3
Vienna 3
Abeokuta 2
Ann Arbor 2
Belgrade 2
Bo 2
Des Moines 2
Naples 2
Parma 2
Pisa 2
Poggio Renatico 2
Rome 2
San Francisco 2
Seattle 2
Victoria 2
Woodbridge 2
Amman 1
Azzano Decimo 1
Brooklyn 1
Buffalo 1
Busseto 1
Cagliari 1
Cambridge 1
Falls Church 1
Frankfurt am Main 1
Glasgow 1
Hangzhou 1
Kilburn 1
Lamezia Terme 1
Los Angeles 1
Madrid 1
Marseille 1
Matera 1
Modena 1
Mülheim 1
Olalla 1
Pittsburgh 1
Redwood City 1
Stockholm 1
The Dalles 1
Totale 346
Nome #
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma 99
null 98
VarianThinker: a classification method to confidently approach the mutation heterogeneity in Multiple Myeloma 71
A Methodologically Updated De-Novo Extraction of Copy Number Signatures in Multiple Myeloma: Clinical Significance and Putative Aetiologies 56
BoBafit: A copy number clustering tool designed to refit and recalibrate the baseline region of tumors’ profiles 55
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients 48
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases 40
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma 20
OAB-057: Temporal-weight estimation of the copy number alterations of of 1384 Multiple Myeloma patients defines an ancestrality index impacting patients survival 16
OAB-006: A novel algorithm to identify, characterize and define the prognostic impact of complex catastrophic events in Multiple Myeloma 8
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients 7
Rare, but complex chromosomal rearrangements, defined "Chromoanagenesis”, caused by single-step or stepwise catastrophic genomic events, significantly impact on Multiple Myeloma patients 5
Abstract 2700: Negative selective pressure exerted by maintenance therapy promotes the extinction of sub-clones carrying high-risk lesions in multiple myeloma 2
Totale 525
Categoria #
all - tutte 1.780
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.780


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 5 3 0 0 7
2021/202286 0 2 2 9 3 3 2 4 7 21 15 18
2022/2023239 13 17 8 16 31 12 7 11 28 10 39 47
2023/2024185 11 10 23 12 8 19 13 77 6 6 0 0
Totale 525